MDS-PB13 Score - Blood based detection of aberrancies by flow cytometry in patients with suspected and confirmed Myelodysplastic Neoplasms

Leukemia. 2024 Feb;38(2):446-450. doi: 10.1038/s41375-024-02141-w. Epub 2024 Jan 16.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Flow Cytometry
  • Humans
  • Immunophenotyping
  • Myelodysplastic Syndromes* / diagnosis
  • Neoplasms*